Poised for Innovation: Considerations for End Points for New Drug Development in Kidney Transplantation

J Am Soc Nephrol. 2024 Nov 1;35(11):1603-1606. doi: 10.1681/ASN.0000000000000475. Epub 2024 Aug 5.

Authors

Roslyn B Mannon¹, Flavio G Vincenti²

Affiliations

¹ Division of Nephrology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska.
² Department of Medicine and Surgery, University of California at San Francisco, San Francisco, California.

PMID: 39102302
PMCID: PMC11543003 (available on 2025-11-01)
DOI: 10.1681/ASN.0000000000000475

No abstract available

Associated data

ClinicalTrials.gov/NCT03744910
ClinicalTrials.gov/NCT04294459

Grants and funding